BIOTECH BOOST: Mylan climbed 5.6 percent to $40.66 after federal regulators approved its version of Amgen's anti-infection drug Neulasta.
News
- US stocks waver; tech and retailers rise but banks fall
- US stocks inch higher; technology and small caps rise
BIOTECH BOOST: Mylan climbed 7.4 percent to $41.34 after federal regulators approved its version of Amgen's anti-infection drug Neulasta.
- Kiromic founder says Houston biotech's move to SA nearly a done deal
Filled with “must read” stories, industry news and reporter insights, exclusive interviews with local business leaders, and expanded Top 25 Lists.
- Two potbellied pigs found roaming SA neighborhoods
Animal Care Services named a Vietnamese potbellied pig roaming a neighborhood North of Prue Road, Tony Porker, after the San Antonio point ...
- San Antonio Joins National Group To Build Cross-Sector STEM Learning
San Antonio is joining more than 60 other cities collaborating to better ... biosciences have been burgeoning industries where San Antonio is poised to ...